Buchang Pharmaceutical adjusts investment payment schedule for subsidiaries

Shandong Buchang Pharmaceuticals (SSE:603858) has announced adjustments to the payment schedules for its investments in six holding subsidiaries. The subsidiaries, established to enhance strategic development and market competitiveness, include Shandong Buchang Golden Key Pharmaceutical Technology Co., Ltd., Jinan Buchang Jianxin Biotechnology Co., Ltd., Shandong Buchang Changyan Biotechnology Co., Ltd., Shandong Buchang Guanyou Medical Device Co., Ltd., Shandong Buchang Zhongxin Kang Pharmaceutical Technology Co., Ltd., and Shandong Buchang Zhenze Pharmaceutical Technology Co., Ltd.